Ologen (OculusGen)-Glaucoma MMC Control in Pakistan
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and effectiveness of the ologen
(OculusGen) Biodegradable Collagen Matrix Implant and the MMC group in filtration surgery.